GlassScriptPhysician profile
Amy Nicole Willcox
NPI 1841434974
$1,031.79
in general payments reported to CMS, 2019-2025
25 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $154 · 2020: $36.38 · 2022: $17.92 · 2023: $139 · 2024: $370 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $811 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.63 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $113.85 | 2024-2025 | Nexplanon, Jada System |
| Aspira Women'S Health INC | $106.22 | 2024 | Ova1 |
| Exeltis, USA INC. | $100.07 | 2022-2025 | Slynd |
| Biogen, INC. | $82.06 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $80.45 | 2019-2023 | |
| Hologic Sales and Service, LLC | $74.36 | 2019-2025 | Aptima |
| Astellas Pharma US INC | $53.31 | 2020-2025 | Veozah |
| Vertex Pharmaceuticals Incorporated | $52.64 | 2024-2025 | |
| Shield Therapeutics INC | $52.27 | 2024 | |
| Smith+Nephew, INC. | $36.61 | 2024 | Pico |
| Coopersurgical, INC. | $33.06 | 2024 | Endosee |
| Merck Sharp & Dohme LLC | $26.45 | 2019-2020 | |
| Boston Scientific Corporation | $25.22 | 2019 | |
| Conmed Corporation | $22.20 | 2024 | Vcare, Airseal, Visiclear |
| Daiichi Sankyo INC. | $22.19 | 2023 | Injectafer |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $19.99 | 2025 | Olympus |
| Abbvie INC. | $17.74 | 2023 | Lo Loestrin Fe |
| Allergan, INC. | $16.91 | 2019 | |
| Lilly USA, LLC | $16.39 | 2024 | Zepbound, Jardiance |
| Medtronic, INC. | $14.86 | 2024 | Truclear |
| Sumitomo Pharma America, INC. | $14.02 | 2023 | Myfembree |
| Ethicon US, LLC | $13.85 | 2023 | Stratafix, Dermabond, Ethicon |
| Millicent US INC | $13.35 | 2023 | Femring |
| Coloplast Corp | $12.59 | 2019 | |
| Pfizer INC. | $11.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Willcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.